Calcitonin Gene-related Peptide Antibody in Acute Mountain Sickness

NCT07653516 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Acute Mountain Sickness

Interventions

DRUG: Fremanezumab 225 Mg/1.5 mL Subcutaneous Solution
DRUG: Placebo

Sponsor

Insel Gruppe AG, University Hospital Bern